Found 27 matching trials
To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension
PHASE1To evaluate the hormonal response to low blood sugar after a single oral do...
To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients
PHASE1The purpose of this study is to assess the safety and tolerability of AZD16...
Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients
PHASE1The purpose of this study is to determine whether AZD1656 will affect the P...
To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients
PHASE1To assess the pharmacokinetics of AZD1656, and its metabolite, in type 2 di...
AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce
PHASE2AZD1656 in Transplantation with Diabetes tO PromoTe Immune TOleraNce: a sin...
Location
Royal London Hospital Barts Health NHS Trust
To Evaluate 24-hr Glucose After OD vs BD AZD1656
PHASE1The purpose of this study is to compare the 24-hour glucose profiles in dia...
Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
PHASE2The purpose of this study is to assess the 1 month safety and tolerability ...
Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients
PHASE2The purpose of this study is to compare the effect on glucose control of 3 ...
Investigate the Effect of AZD1656 on the Pharmacokinetics of Sitagliptin in Patients With Type 2 Diabetes Mellitus
PHASE1The purpose of this study is to evaluate the effects of AZD1656 on Sitaglip...
Safety and Tolerability of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients Treated With Metformin and Sulfonylurea
PHASE1The primary aim of this study is to evaluate the safety and tolerability of...